NCT02345304View on ClinicalTrials.gov

Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

Omeprazole

DRUG

Warfarin

DRUG

BI 1181181

DRUG

Midazolam

DRUG

Omeprazole

DRUG

BI 1181181

DRUG

Midazolam

DRUG

Midazolam

DRUG

Warfarin

DRUG

BI 1181181

DRUG

Digoxin

DRUG

Digoxin

Trial Locations (1)

Unknown

1344.3.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY